EU indices slightly up | TA focus on Julius Baer


European stocks report | AstraZeneca | Volkswagen | Philips | Julius Baer ...

Stocks (1)

Friday, European stocks were still in positive territory. The Stoxx Europe 600 Index rebounded 1.26%, Germany's DAX 30 rose 1.62%, France's CAC 40 jumped 2.03%, and the U.K.'s FTSE 100 was up 1.49%.

76% of STOXX 600 constituents traded higher Friday.
63% of the shares trade above their 20D MA vs 53% Thursday (above the 20D moving average).
60% of the shares trade above their 200D MA vs 58% Thursday (above the 20D moving average).

The Euro Stoxx 50 Volatility index eased 1.53pt to 25.32, a new 52w high.

3mths relative high: Pers. & House. Goods, Media, Industrial
3mths relative low: Insurance

Europe Best 3 sectors
automobiles & parts, personal & household goods, banks

Europe worst 3 sectors
real estate, telecommunications, travel & leisure

The 10yr Bund yield fell 3bps to -0.61% (below its 20D MA). The 2yr-10yr yield spread rose 0bp to -15bps (above its 20D MA), a new 3mths high.

EC 10:00: Aug Construction Output YoY, exp.: -3.8%
FR 14:00: 12-Mth BTF auction, exp.: -0.63%
FR 14:00: 6-Mth BTF auction, exp.: -0.64%
FR 14:00: 3-Mth BTF auction, exp.: -0.66%

On Sunday, House Speaker Nancy Pelosi called on the government to reconcile remaining disputes on stimulus legislation within 48 hours in an attempt to pass a bill before the 2020 election. Comments by Pelosi helped in raising market optimism about progress on an agreed deal between the government and Congress. U.S. stock index futures jumped in early Asian trading hours on Monday. During Asian sessions, EUR/USD was little changed at 1.1715 while GBP/USD advanced to 1.2937. USD/JPY was broadly flat at 105.37. This morning, official data showed that Japan's exports fell 4.9% on year in September (-2.4% expected) and imports declined 17.2% (-21.4% on year expected). AUD/USD marked a day-high near 0.7108 before easing back to 0.7095. Earlier today, government data showed that China's 3Q GDP grew 4.9% on year (+5.5% expected), while industrial production rose 6.9% in September (+5.8% expected) and retail sales increased 3.3% (+1.7% expected).

Spot gold edged up to $1,901 an ounce.

AstraZeneca, a pharmaceutical group, said its Trixeo Aerosphere has been recommended for approval in the European Union by the Committee for Medicinal Products for Human Use (CHMP) for the maintenance treatment of chronic obstructive pulmonary disease. At the same time, its Forxiga has also been recommended for approval by CHMP in the region for the treatment of symptomatic chronic heart failure.

Volkswagen's, an automobile group, Traton announced that it has agreed to acquire the remaining stake in American trucks and diesel engines company Navistar for 44.50 dollars per share, representing about 3.7 billion dollars.

Philips, a Dutch multinational conglomerate, announced that 3Q net income jumped 63% on year to 340 million euros and EBITA grew 32% to 769 million euros on revenue of 4.98 billion euros, up 6% (+10% on a comparable basis). The company said it targets an acceleration of the average annual comparable sales growth to 5-6% for the 2021-2025 period, but expects a low-single-digit growth for 2021.

Julius Baer, a Swiss private bank, said assets under management rose 3% on quarter (-3% on year) to 413 billion Swiss franc in 3Q and annualized growth of net new money inflows was close to 4% in the 9-month period, compared with 2.3% in 1H and 2.8% for full-year 2019.

From a weekly point of view, the consolidation channel's upward breakout would call for a new measured move up to 50CHF at least (horizontal resistance from April 2019) and 56.5CHF in extension (neckline of a 2017/2018 head-and-shoulders pattern and upper end of a bearish gap set on 2018, July 23rd).

Source: TradingView, GAIN Capital

More from Equities


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.